Intermittent Theta Burst Stimulation for Depression

This trial tests a new method called accelerated intermittent theta burst stimulation (iTBS), which uses magnetic fields to boost brain activity, to determine its effectiveness in reducing depression symptoms. Participants will receive either the real iTBS treatment or a placebo, and researchers will compare the outcomes. They will also examine changes in brain and body markers, as well as emotions, to see if these correlate with treatment effectiveness. The study seeks English-speaking adults diagnosed with major depression who are not currently using certain medications or substances. As an unphased trial, it offers participants the chance to contribute to groundbreaking research that could lead to new treatment options for depression.

You may need to stop taking certain medications, like benzodiazepines, that could interfere with the TMS treatment. It's best to discuss your current medications with the study team to see if any changes are needed.

Research has shown that intermittent theta burst stimulation (iTBS) is generally safe for treating depression. Studies have found that most people tolerate iTBS well. For example, a recent analysis demonstrated that real iTBS outperformed placebo treatments in improving depression symptoms, without major safety concerns.

In another study involving teenagers, iTBS proved safe and effective, though its benefits diminished over time, indicating the potential need for repeated sessions to maintain effects. Another report found that side effects were similar to those of other treatments, with most participants not experiencing serious issues.

Intermittent Theta Burst Stimulation (iTBS) is unique because it offers a non-invasive, rapid treatment option for depression, setting it apart from standard treatments like antidepressants and psychotherapy. Unlike medications that can take weeks to show effects, iTBS has the potential to provide noticeable improvement within days by using brief, high-frequency bursts of magnetic pulses to stimulate brain activity. Researchers are excited about iTBS because it targets specific brain areas linked to mood regulation, potentially leading to faster and more targeted relief for patients with depression.

Research has shown that intermittent theta burst stimulation (iTBS), a treatment available in this trial, can reduce symptoms of major depressive disorder (MDD). Studies indicate that iTBS helps 30% to 60% of people feel better, with 10% to 40% experiencing complete relief from symptoms. Specifically, one study found that about 69% of patients improved with iTBS, and nearly half saw their symptoms disappear entirely within four weeks. iTBS is also considered safe and effective for individuals who haven't found success with other depression treatments. It uses magnetic fields to stimulate specific brain areas, potentially improving mood and reducing depression symptoms.³⁴⁶⁷⁸